Multifocals: Careful pre-op preparation minimises explantation

Article

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs.

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs, Dr Risto Uusitalo of the Helsinki Eye Clinic said.

"There is a stacking effect, where a number of small errors stack up into a large error. That is why it is vital to get precise biometry, and select appropriate patients," explained Dr Uusitalo.

Exclusion criteria include astigmatism greater than 1.0 D, pre-existing ocular pathology, such as very dense cataract where you can't see the fundus properly, and previous refractive procedure. Physical data is not enough, assessing the psychological profile is also vital.

"A teacher once told me, if your patient has more than three pens in his pocket, be careful. They are typically physicians, architects, engineers and artists. They are perfectionists, they have unrealistic expectations and they are less likely to be happy with loss in vision quality," Dr Uusitalo said.

Similarly, professions that depend on the quality of vision should be excluded too, for example truck drivers.

Dr Uusitalo concluded that multifocal IOLs pose some risks that cannot be ignored, these can, however, be reduced and, overall, the benefits outweigh the risk, for the right patient.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.